FDA Stakeholders Meeting For Chronic Fatigue Syndrome II: Barriers, Breakthroughs and Possibilities For Drug Development
Bernard Munos' daunting but ultimately inspiring talk on what the ME/CFS field needed to do to attract pharma suggested we may be closer than we think.
Patients Give FDA the Scoop on ME/CFS in First Day of FDA Stakeholder Meeting
“There’s an unmet medical need right here and there has been for a long time” Bob Miller The first day of the FDA Stakeholders Meeting was like an patient/FDA roundtable session focusing on what symptoms are worst and what treatments worked best....Last Chance To Register or Comment Plus Surveys and Webinars Galore for Chronic Fatigue Syndrome FDA Stakeholders Meeting
Today is the last day for patients to register or provide comments to the FDA Stakeholder Meeting on April 25th/26. This meeting is turning out to be a bigger deal than we knew. Not only will it light a fire under the FDA to get moving on chronic fatigue syndrome but...Oh No! ME/CFS Community MIA Thus Far on Historic Opportunity: FDA Drug Development Workshop Needs Your Comments!
The opportunity for the chronic fatigue syndrome to submit comments regarding drug effectiveness to the FDA Stakeholder Meeting is fast closing.FDA Stakeholder Workshop in Trouble? FDA Disavowal of ME/CFS Expert Sows Concern
The FDA's misconception regarding Dr. Peterson; that he only uses Ampligen to treat patients brings into question how seriously they're taking this workshop.Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
